Health Care Committee

Advocating for Accessible and Innovative Healthcare

Chair

Jurica Toth

Medtronic Adriatic d.o.o.

Vice-Chair

Ivo Šegota

Merck Sharp & Dohme d.o.o.

AmCham coordinator

Tomislav Vidović

mail tomislav.vidovic@amcham.hr

2026 Policy Issues

1. Value of Innovation in Healthcare
  • Patients in Croatia often have more limited range of available new and innovative medicines compared to patients in many other EU. Limited availability of innovative therapies affects patient outcomes and puts additional pressure on the healthcare system, highlighting the importance of how new medicines are evaluated, introduced, and made accessible in everyday healthcare.
2. Regulation on the Inclusion of Medicines on the Reimbursement List
  • The Ordinance that defines the reimbursement procedure and determine which medicines are covered by public health insurance in Croatia is expected to change to reflect new EU requirements and recent updates to national medicine legislation. These rules play a key role in how quickly and under what conditions medicines become available to patients through the public healthcare system.
3. Private Healthcare as a Partner of the Public System
  • The role of private healthcare in the public system is not clearly defined and which results in a limited collaboration while the public sector is under increased pressure. By examining opportunities for collaboration, public-private partnerships in targeted areas of healthcare, with the potential to alleviate the burden on public system should be encouraged.

The Committee will monitor all legal changes during 2026 by the Ministry of Health and other competent authorities and react as necessary. Committee will also work on the topic of sustainable healthcare financing jointly with the Trade and Investment Committee.

Additional topics outside the plan that Committee will continue advocating are Health Technology Assessment and Obesity Treatment.

Representatives of the following member companies participate in the work of the Committee: 

Altium International d.o.o.
Abbott Laboratories d.o.o.
AbbVie d.o.o.
Alpheus d.o.o.
Altium International d.o.o.
Amgen d.o.o.
AstraZeneca d.o.o.
Bayer d.o.o.
Becton Dickinson Croatia d.o.o.
CMS Reich-Rohrwig Hainz Rechtsanwälte GmbH - Podružnica Zagreb
Cromedic Assistance d.o.o.
Eli Lilly Hrvatska d.o.o.
Fresenius Kabi d.o.o.
Genesis Pharma Adriatic d.o.o.
Grayling d.o.o.
Hrvatski Telekom d.d.
Hrvatsko-američko društvo
International Medical Corps Croatia/Međunarodni Medicinski Zbor Hrvatska
IQVIA Adriatic d.o.o.
Johnson & Johnson S.E. d.o.o.
Kiara Maria d.o.o.
Klaster zdravstvenog turizma Kvarnera
Mastercard Europe - Podružnica Zagreb
McKinsey & Company, Inc. Adriatic Podružnica
Medical Intertrade d.o.o.
Medilab One d.o.o.
Medtronic Adriatic d.o.o.
MERCK d.o.o.
Merck Sharp & Dohme d.o.o.
Novartis Hrvatska d.o.o.
Novo Nordisk Hrvatska d.o.o.
Odvjetničko društvo Ilej & Partneri d.o.o.
Odvjetnik Mario Perica
Oktal Pharma d.o.o.
Olympus Czech Group, s.r.o., član koncerna, Podružnica Zagreb
Pfizer Croatia d.o.o.
Philip Morris Zagreb d.o.o.
PHILIPS d.o.o.
Roche d.o.o.
Rud Pedersen Croatia d.o.o.
SANDOZ d.o.o.
Sofmedica Croatia d.o.o.
SOLE-COMMERCE d.o.o.
Solvership d.o.o.
Swixx BioPharma d.o.o.
Takeda Pharmaceuticals Croatia d.o.o
TDR d.o.o.
Viatris Hrvatska d.o.o.
Visa Europe Management Services Limited, Podružnica Zagreb
Vlahović Grupa d.o.o. - Vlahovic Group Government Relations
Wiener osiguranje Vienna Insurance Group d.d.